Aktis Oncology, Inc. (AKTS)
| Market Cap | 1.18B |
| Revenue (ttm) | 5.56M |
| Net Income (ttm) | -60.65M |
| Shares Out | 52.52M |
| EPS (ttm) | -76.44 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,985,308 |
| Open | 27.00 |
| IPO Price | 18.00 |
| Day's Range | 19.33 - 29.16 |
| 52-Week Range | 18.00 - 29.16 |
| Beta | 1.69 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About AKTS
Aktis Oncology, Inc. develops and manufactures precision radiopharmaceutical therapies for cancer treatment. The company focuses on solid tumors with limited treatment options, engineering targeted therapies that utilize alpha-emitting particles to deliver cancer-killing effects while minimizing exposure to healthy tissue. It employs a theranostic approach, using imaging tools to visualize and verify tumor targeting, and to predict patient response. The company manages logistics and just-in-time delivery of its radiopharmaceuticals to ensure ti... [Read more]
News
U.S. IPO Weekly Recap: Aktis Oncology Leads As First Sizable 2026 IPO
U.S. IPO Weekly Recap: Aktis Oncology Leads As First Sizable 2026 IPO
Vida Ventures Congratulates Aktis Oncology on Its Entry into the Public Markets
LOS ANGELES & BOSTON--(BUSINESS WIRE)--Vida Ventures (“Vida”), a next-generation life sciences venture firm, today congratulates Aktis Oncology (Nasdaq: AKTS), a clinical-stage biotechnology company a...
Aktis Oncology prices upsized US IPO at $18 per share
Cancer drug developer Aktis Oncology said on Thursday it priced its upsized U.S. initial public offering at $18 per share, raising about $318 million.
Aktis Oncology Announces Pricing of its Upsized Initial Public Offering
BOSTON, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Aktis Oncology, Inc. (“Aktis”), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large pa...
Aktis Oncology Pursues $200 Million IPO On Promising Early Stage Studies
Aktis Oncology, Inc. seeks $200 million in IPO funding to advance radiopharmaceutical candidates for solid tumor cancers. AKTS's lead asset [225Ac]Ac-AKY-1189 is in Phase 1b trials, with preliminary r...
U.S. IPO Weekly Recap: Small Issuers And SPACs Join The Pipeline In Short Holiday Week
Seven IPOs and two SPACs submitted filings this week; no pricings this week. The IPO calendar looks quiet for the week ahead, with one small issuer tentatively slated to debut. Street research is expe...
Akoustis Successfully Completes Sale of Assets to SpaceX
CHARLOTTE, N.C.--(BUSINESS WIRE)--Akoustis Technologies, Inc. (together with its wholly-owned subsidiaries Akoustis, Inc. and RFM Integrated Device Inc., “Akoustis” or the “Company”), an integrated de...
Akoustis to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process
Committed to Full Continuity in Delivering Next-Generation BAW High-Band RF Filters to Customers Around the World Filing to Ensure Business Sold Free and Clear of Qorvo Infringement Following Final Ju...
Akoustis Secures $8 Million in Volume XBAW® Orders with Tier-1 Customer
Charlotte, N.C., July 09, 2024 (GLOBE NEWSWIRE) -- Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), an integrated device manufacturer (IDM) of patented bulk acoustic wave (BAW...
Akoustis Receives $2 Million in Volume Orders for Wi-Fi 7 Program from Tier-1 Carrier
Charlotte, N.C., June 27, 2024 (GLOBE NEWSWIRE) -- Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), an integrated device manufacturer (IDM) of patented bulk acoustic wave (BAW...
Akoustis Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Charlotte, N.C., May 22, 2024 (GLOBE NEWSWIRE) -- Akoustis Technologies, Inc. (Nasdaq: AKTS) (“Akoustis” or the “Company”), an integrated device manufacturer (IDM) of patented bulk acoustic wave (BAW)...
Akoustis Completes Rollout of its XBAW® Design Updates
Charlotte, N.C., May 22, 2024 (GLOBE NEWSWIRE) -- Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), an integrated device manufacturer (IDM) of patented bulk acoustic wave (BAW)...
Akoustis Technologies, Inc. (AKTS) Q3 2024 Earnings Call Transcript
Akoustis Technologies, Inc. (NASDAQ:AKTS) Q3 2024 Earnings Conference Call May 13, 2024 8:00 AM ET Company Participants Kenneth Boller - CFO Jeffrey Shealy - Founder & CEO Drew Wright - Corporate Gen...
Akoustis Reports Third Quarter FY24 Results
Q3 Revenue Up 7% Quarter-Over-Quarter Filter-Related Revenue Up 13% Quarter-Over-Quarter, Third Highest in Company History Growth, Cost Savings Initiatives, CHIPS Act ITC Refund Support Operating Cash...
Akoustis Receives Two Design Wins with Tier-1 Network Infrastructure Customer
Tier-1 Customer to Use High-Performance Akoustis XBAW® Filters for Two Wi-Fi 7 Fixed Wireless Access Enterprise and Home Gateway Platforms Company Has Received Orders to Support Production Ramp Throug...
Akoustis Secures Design Win and Volume Orders for Wi-Fi 7 Solution with Tier-1 Enterprise Class OEM
Charlotte, N.C., April 08, 2024 (GLOBE NEWSWIRE) -- Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), an integrated device manufacturer (IDM) of patented bulk acoustic wave (BA...
Akoustis Introduces Two New 2.4 GHz BAW RF Filters for Wi-Fi Automotive and Access Point Applications
Charlotte, N.C., April 03, 2024 (GLOBE NEWSWIRE) -- Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), an integrated device manufacturer (IDM) of patented bulk acoustic wave (BA...
Akoustis to Attend the 36th Annual Roth Conference on March 17-19, 2024
Charlotte, N.C., March 11, 2024 (GLOBE NEWSWIRE) -- Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), an integrated device manufacturer (IDM) of patented bulk acoustic wave (BA...
Akoustis to Attend GOMACTech 2024 in Charleston from March 19-20
Charlotte, N.C., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), an integrated device manufacturer (IDM) of patented bulk acoustic wave (BAW...
Akoustis Technologies, Inc. (AKTS) Q2 2024 Earnings Call Transcript
Akoustis Technologies, Inc. (AKTS) Q2 2024 Earnings Call Transcript
Akoustis Reports Second Quarter FY24 Results
Q2 Revenue Up 20% Year-Over-Year, In-Line with Prior Guidance Guiding Record Quarterly Revenue for the March Quarter—Up 18 to 25% Sequentially Growth, Cost Savings Initiatives, CHIPS Act ITC Refund Su...
Akoustis Receives Wi-Fi 7 Design Win from Tier-1 US-Based Carrier
Tier-1 Customer to Use Akoustis' Next-Generation 5.5 and 6.5 GHz Wi-Fi 7 XBAW® Filters in 4x4 MIMO Router Platform Secures Wi-Fi 7 Filter Orders to Support Production Ramp in September Quarter of Cale...
Akoustis Achieves Wi-Fi 7 Design Win and Volume Orders for Two New Programs from Current Tier-1 Enterprise Wi-Fi AP Solutions Provider
Tier-1 Customer to Use Multiple Akoustis XBAW® Filters in 4X4 and 2X2 MU-MIMO Enterprise Access Point Platforms Has Received Volume Orders to Facilitate Production Ramp in the Second Half of Calendar ...
Akoustis to Webcast Q2FY24 Results on February 13 at 8:00 am ET
Charlotte, N.C., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), an integrated device manufacturer (IDM) of patented bulk acoustic wave (BAW...
Akoustis Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriter's Option to Purchase Additional Shares
Charlotte, N.C., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), an integrated device manufacturer (IDM) of patented bulk acoustic wave (BAW...